drugset / Trial / NCT00439686

Study of ZIO-201 in Advanced Sarcoma

NCT00439686 ↗

Phase 1/2 Completed 54 enrolled Alaunos Therapeutics
Non-randomizedSequentialOpen-labelTreatment

Summary

The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced sarcoma.

Timeline

Start
2006-02-21
Primary completion
2008-01-16
Completion
2008-01-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Palifosfamide Small molecule 178 mg/m2 Intravenous
Subject Palifosfamide Small molecule 413 mg/m2 Intravenous
Subject Palifosfamide Small molecule 590 mg/m2 Intravenous

Indications